Multiplex Assays Market: Adoption of Multiplex Assays as Potential Substitutes for Singleplex Multiplex Assays Favor Growth
Rising instances of infectious maladies and elaborate R&D on new drug development remain potential growth initiators for multiplex assays market. Significant advantages of multiples assays over singleplex assays further necessitate substantial adoption, thereby fuelling ample market growth. Advances in diagnostic processes on the back of growing burden of cancer and other chronic diseases further augment adoption and corresponding growth of multiplex assays.
View full press release